Free Trial

Stevanato Group S.p.A. (NYSE:STVN) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Stevanato Group logo with Medical background

Key Points

  • Stevanato Group S.p.A. (NYSE:STVN) has received an average rating of "Moderate Buy" from brokerages, with mixed recommendations including two holds, four buys, and one strong buy.
  • The company recently announced an increase in its annual dividend to $0.0613 per share, up from the previous annual dividend of $0.05, reflecting a yield of 0.3%.
  • Stevanato Group's shares are currently trading at approximately €26.18 ($30.80), having fallen 6.3%, with a market cap of $7.93 billion and a PE ratio of 51.33.
  • Interested in Stevanato Group? Here are five stocks we like better.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven analysts that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company.

A number of equities analysts have recently commented on the company. William Blair reiterated an "outperform" rating on shares of Stevanato Group in a research note on Monday, June 30th. Stephens raised Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st.

View Our Latest Stock Analysis on Stevanato Group

Stevanato Group Stock Down 6.3%

Shares of STVN traded down €1.77 ($2.08) during mid-day trading on Friday, hitting €26.18 ($30.80). 414,900 shares of the company's stock were exchanged, compared to its average volume of 253,668. The firm has a fifty day moving average of €24.22 and a two-hundred day moving average of €22.32. Stevanato Group has a twelve month low of €17.12 ($20.14) and a twelve month high of €28.00 ($32.94). The stock has a market cap of $7.93 billion, a price-to-earnings ratio of 49.09, a P/E/G ratio of 2.66 and a beta of 0.55. The company has a quick ratio of 1.26, a current ratio of 1.83 and a debt-to-equity ratio of 0.22.

Stevanato Group Increases Dividend

The business also recently disclosed an annual dividend, which was paid on Thursday, July 17th. Shareholders of record on Thursday, June 5th were issued a dividend of $0.0613 per share. The ex-dividend date was Thursday, June 5th. This represents a yield of 0.3%. This is a positive change from Stevanato Group's previous annual dividend of $0.05.

Institutional Trading of Stevanato Group

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in STVN. Lindenwold Advisors INC bought a new position in Stevanato Group during the second quarter worth about $229,000. Bar Harbor Wealth Management acquired a new position in shares of Stevanato Group in the 2nd quarter valued at approximately $9,081,000. Hilltop National Bank acquired a new position in Stevanato Group in the 2nd quarter worth $158,000. Truist Financial Corp boosted its stake in Stevanato Group by 9.5% in the 2nd quarter. Truist Financial Corp now owns 32,029 shares of the company's stock worth $782,000 after purchasing an additional 2,781 shares during the period. Finally, Diversified Trust Co acquired a new position in shares of Stevanato Group during the second quarter worth about $352,000.

About Stevanato Group

(Get Free Report

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Featured Stories

Analyst Recommendations for Stevanato Group (NYSE:STVN)

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines